{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:18:50Z","timestamp":1772151530917,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,11,24]]},"DOI":"10.1253\/circj.cj-22-0687","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T22:11:48Z","timestamp":1687212708000},"page":"1820-1827","source":"Crossref","is-referenced-by-count":10,"title":["Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure\u3000\u2015 A Real-World Study \u2015"],"prefix":"10.1253","volume":"87","author":[{"given":"Satoko","family":"Ryuzaki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyo","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Advanced Cardiorhythm Therapeutics, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatsugu","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Advanced Cardiorhythm Therapeutics, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pisters R, Lane DA, Nieuwlaat R, Vos CB, Crijns H, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. <i>Chest<\/i> 2010; 138: 1093\u20131100.","DOI":"10.1378\/chest.10-0134"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. <i>Circulation<\/i> 2011; 123: 2736\u20132747.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, et al; the Japanese Circulation Society\/the Japanese Heart Rhythm Society Joint Working Group. JCS\/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2022; 86: 337\u2013363, doi:10.1253\/circj.CJ-21-0162.","DOI":"10.1253\/circj.CJ-21-0162"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. <i>Lancet<\/i> 2009; 374: 534\u2013542.","DOI":"10.1016\/S0140-6736(09)61343-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. <i>J Am Coll Cardiol<\/i> 2014; 64: 1\u201312.","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA, et al. Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation. <i>J Am Coll Cardiol<\/i> 2022; 79: 1785\u20131798.","DOI":"10.1016\/j.jacc.2022.02.047"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Li SY, Wang J, Hui X, Zhu HJ, Wang BY, Xu H. Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion. <i>J Int Med Res<\/i> 2020; 48: 300060520966478, doi:10.1177\/0300060520966478.","DOI":"10.1177\/0300060520966478"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. S\u00f8ndergaard L, Wong YH, Reddy VY, Boersma LVA, Bergmann MW, Doshi S, et al. Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN. <i>JACC Cardiovasc Interv<\/i> 2019; 12: 1055\u20131063.","DOI":"10.1016\/j.jcin.2019.04.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Li W, Gao R, Zhao J, Ren Y, Chen G, Zhu J, et al. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion. <i>Ann Palliat Med<\/i> 2022; 11: 201\u2013209.","DOI":"10.21037\/apm-21-3654"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kemi Y, Yamashita E, Fujiwara T, Kario K, Sasaki T, Minami K, et al. The prevalence and characteristics of candidates for percutaneous left atrial appendage occlusion using a WATCHMAN device among patients who underwent atrial fibrillation ablation in a Japanese population. <i>J Echocardiogr<\/i> 2021; 19: 243\u2013249.","DOI":"10.1007\/s12574-021-00538-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Aonuma K, Yamasaki H, Nakamura M, Ootomo T, Takayama M, Ando K, et al. Percutaneous WATCHMAN left atrial appendage closure for Japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism: First results from the SALUTE trial. <i>Circ J<\/i> 2018; 82: 2946\u20132953.","DOI":"10.1253\/circj.CJ-18-0222"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Aonuma K, Yamasaki H, Nakamura M, Matsumoto T, Takayama M, Ando K, et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in Japanese nonvalvular atrial fibrillation patients: Final 2-year follow-up outcome data from the SALUTE trial. <i>Circ J<\/i> 2020; 84: 1237\u20131243.","DOI":"10.1253\/circj.CJ-20-0196"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. <i>JAMA<\/i> 2001; 285: 2864\u20132870.","DOI":"10.1001\/jama.285.22.2864"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. <i>Chest<\/i> 2010; 137: 263\u2013272.","DOI":"10.1378\/chest.09-1584"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tzikas A, Holmes DR Jr, Gafoor S, Ruiz CE, Blomstr\u00f6m-Lundqvist C, Diener HC, et al. Percutaneous left atrial appendage occlusion: The Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. <i>Europace<\/i> 2017; 19: 4\u201315.","DOI":"10.1093\/europace\/euw141"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al; JCS\/JHRS Joint Working Group. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2021; 85: 1104\u20131244, doi:10.1253\/circj.CJ-20-0637.","DOI":"10.1253\/circj.CJ-20-0637"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fukunaga M, Isotani A, Shirai S, Murakami N, Nakamura M, Morinaga T, et al. Initial practice of left atrial appendage closure device in Japan; single-center experience. <i>J Cardiol<\/i> 2022; 79: 752\u2013758.","DOI":"10.1016\/j.jjcc.2022.01.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Reddy VY, Gibson DN, Kar S, O\u2019Neill W, Doshi SK, Horton RP, et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. <i>J Am Coll Cardiol<\/i> 2017; 69: 253\u2013261.","DOI":"10.1016\/j.jacc.2016.10.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Reddy VY, M\u00f6bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: The ASAP study (ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology). <i>J Am Coll Cardiol<\/i> 2013; 61: 2551\u20132556.","DOI":"10.1016\/j.jacc.2013.03.035"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ben H, Changsheng M, Shulin W. 2019 Chinese expert consensus statement on left atrial appendage closure in patients with atrial fibrillation. <i>Pacing Clin Electrophysiol<\/i> 2022; 45: 535\u2013555.","DOI":"10.1111\/pace.14448"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, et al. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion: An update. <i>EuroIntervention<\/i> 2020; 15: 1133\u20131180.","DOI":"10.4244\/EIJY19M08_01"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rocca DGD, Magnocavallo M, Biase LD, Mohanty S, Trivedi C, Tarantino N, et al. Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion. <i>JACC Cardiovasc Interv<\/i> 2021; 14: 2353\u20132364.","DOI":"10.1016\/j.jcin.2021.07.031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cepas-Guillen PL, Flores-Umanzor P, Regueiro A, Brugaletta S, Iba\u00f1ez C, Sanchis L, et al. Low dose of direct oral anticoagulants after left atrial appendage occlusion. <i>J Cardiovasc Dev Dis<\/i> 2021; 8: 142.","DOI":"10.3390\/jcdd8110142"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schwartz RS, Holmes DR, Tassel RAV, Hauser R, Henry TD, Mooney M, et al. Left atrial appendage obliteration: Mechanisms of healing and intracardiac integration. <i>JACC Cardiovasc Interv<\/i> 2010; 3: 870\u2013877.","DOI":"10.1016\/j.jcin.2010.04.017"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN, et al. Device-related thrombus after left atrial appendage closure: Incidence, predictors, and outcomes. <i>Circulation<\/i> 2018; 138: 874\u2013885.","DOI":"10.1161\/CIRCULATIONAHA.118.035090"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Simard T, Jung RG, Lehenbauer K, Piayda K, Praco\u0144 R, Jackson GG, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. <i>J Am Coll Cardiol<\/i> 2021; 78: 297\u2013313.","DOI":"10.1016\/j.jacc.2021.04.098"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, et al. Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure. <i>JACC Cardiovasc Interv<\/i> 2019; 12: 1067\u20131076.","DOI":"10.1016\/j.jcin.2018.11.001"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/12\/87_CJ-22-0687\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:14:14Z","timestamp":1700882054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/12\/87_CJ-22-0687\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-22-0687","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"article-number":"CJ-22-0687"}}